So that is the consideration. What I can say today, as far as the process, which is the second part of your question, is that presently, we do not plan to return to our historical cadence of a yearly capital actions announcement in January. Instead, while still not decided, moving forward, we will probably shift to capital management process that is closer to what most other banks do, where we will periodically announce stock repurchase authorization that may be executed from time to time. So this is – so we can tell you so far and the process, we always advise the regulators and anything we’re doing with regards to capital. It will be no different this time. And hopefully, get back to you late in the third quarter with a decision on the dividend.
Alexander Twerdahl: Okay. That’s good information. I mean just in terms of that process, like suppose we got some clarity on rates as early as today and some clarity on regulation tomorrow and economy we’re never going to get clarity on. But how long would it take you to actually go through that like the whole process with the Fed. Is that something that is a pretty quick thing? I remember when you guys did the Evertec thing. This seems like the approval happened basically almost overnight. I’m just curious if that’s evolved and gotten any easier over the years.
Carlos Vazquez: I mean, the Fed always has the option to decide everything on their timetable. But the fact is that we’ve been working very effectively with our regulators over the last few years. Frankly, you’ve seen it and what you mentioned on the approval in Evertec is a reflection of it that we try to work closely with them. We’re trying to never surprise them. They are always informed of what we’re trying to do. And if they have to be involved they have been very responsive in working with us if we have a timetable that we’re trying to meet. So our relationship is very good and over the years, they’ve gotten better understanding what we’re doing. We’re gotten better of asking the right questions.
Alexander Twerdahl: Got it. And then one final question for me. I wanted to just to sort of dig into a conversation we haven’t talked about in probably a couple of conference calls, but M&A in the North American franchise. And it just seems to me like we’re hearing anecdotally and seeing more announcements of loan sales. Some of them related to specific asset classes that you may or may not want to be into, some of them related to rates. But it seems like there’s going to be potentially a bunch of loan sales coming up, even some from the FDIC that are going to be potentially coming at pretty big discounts. I’m curious, you guys have tons of capital in North America. If you have appetite to do some loan purchases? And if so, what the criteria might be?
Ignacio Alvarez: Yes. This is Ignacio. I think we’ve said it before, we view ourselves as opportunistic buyers of assets. So there’s pools of assets that interest us, we will definitely go there. I think the assets that would interest us would be mostly those things that we are – we feel we have a certain level of expertise in. So we have a certain level of expertise in CRE, our healthcare financing, the kind of mini association financing, those are things that would be of interest to us. So we’re not going to buy office portfolios at a discount, that kind of thing, even if it’s a very attractive price, we’re not going to do something because that’s not something that we have a particular level of expertise. I don’t think we’d probably go after mortgage assets either. So I think it will be more in the commercial area. But if there are attractive assets in those areas that we feel we know well, we would be interested to look at them, sure.
